Publish in this journal
Journal Information
Vol. 12. Issue 1.
Pages 54-56 (January - February 2016)
Vol. 12. Issue 1.
Pages 54-56 (January - February 2016)
Images in Clinical Rheumatology
DOI: 10.1016/j.reumae.2015.11.003
Full text access
Ultrasonography as a Diagnostic Tool for Skin Metastasis of a Prostate Adenocarcinoma
Ecografía en el diagnóstico de metástasis cutánea de adenocarcinoma de próstata
Hèctor Corominas
Corresponding author

Corresponding author.
, Paula Estrada, Delia Reina, Dacia Cerdà-Gabaroi
Servei de Reumatologia, Hospital Moisès Broggi/Hospital General de L’Hospitalet, Consorci Sanitari Integral (CSI), Sant Joan Despí/L’Hospitalet, Barcelona, Spain
Article information
Full Text
Download PDF
Figures (4)
Show moreShow less
Full Text
Case Report

The patient was a 53-year-old man with no significant medical history. He presented with a painless mass in anterior forearm, reporting no previous injury. Physical examination confirmed the presence of a hard, immobile mass measuring less than 1cm. He came to the rheumatologic examination room, where he underwent soft tissue ultrasound (Toshiba Aplio®300). A round mass measuring less than 1cm was observed. It was iso/hypoechoic on gray scale images, was moderately well-defined, and was joined to a vessel that fed it (Fig. 1). On color Doppler, there was high echo intensity throughout the entire lesion, more intense on the periphery (Figs. 2 and 3). As there were findings that raised suspicion, such as heterogeneity, the marked vascularity and the marked Doppler signal (grade 3), magnetic resonance imaging was performed. This study revealed a round, well-defined form measuring 1cm, with hyperintensity on T1-weighted images, which pointed to a metastatic lesion (Fig. 4).

Figure 1.

(A) Gray scale iso/hypoechoic image of a round, heterogeneous and moderately well-defined lesion. (B) Image with Doppler signal activated showing the vessel that feeds the metastatic lesion.

Figure 2.

Color Doppler image showing the hypervascularity of the highly heterogeneous lesion, findings that rule out malignancy.

Figure 3.

Doppler image showing a round form and grade 1 signal in the lesion and hypervascularity due to an adjacent vessel.

Figure 4.

T1-weighted magnetic resonance image (sagittal plane) of the forearm. Round, well-defined iso/hyperintense mass in the muscle of right forearm, with chemical shift artifact with fat saturation.

Diagnosis and Course

While the clinical picture was being completed on the basis of the constitutional symptoms, a biopsy of the skin lesion was carried out. The analysis of 4 tissue cores, measuring 0.4, 1.2, 1 and 0.9cm in length, respectively, and 0.1cm in diameter, confirmed the presence of infiltration of the fibromuscular tissue by prostate-specific antigen (PSA)-positive metastatic adenocarcinoma cells. In addition, laboratory tests revealed a PSA level of 13ng/mL, and transrectal ultrasound-guided biopsy of the prostate confirmed prostatic adenocarcinoma with distant cutaneous metastasis.


After skin cancer, adenocarcinoma of the prostate represents the most common type of cancer in men and the second most common cause of death due to cancer. Death is often associated with metastatic disease which, in the case of prostatic adenocarcinoma, typically involves the bones and lymph nodes. It rarely affects the skin.1,2 Although the medical history and physical examination, laboratory tests and routine pathology may indicate the prostate as the origin of the metastatic disease, immunohistochemistry for PSA is often used to aid in establishing the diagnosis.3

This case is useful in clinical practice in rheumatology because: (1) the images can raise suspicion for the seriousness of a nodular lesion smaller than 1cm because of its vascularity and heterogeneity; (2) it highlights the importance of the rheumatologic examination room in the diagnosis of soft tissue tumors (benign or malignant) that rheumatologists should not disregard; (3) cutaneous metastases of prostatic adenocarcinoma are very uncommon and, in this case, soft tissue ultrasound helped to orientate the extensive study of the neoplastic disease; and (4) it is essential to identify the lesions on the basis of their ultrasonographic appearance and, when in doubt, the study should be extended to include magnetic resonance imaging.4

Ethical DisclosuresProtection of human and animal subjects

The authors declare that no experiments were performed on humans or animals for this study.

Confidentiality of data

The authors declare that they have followed the protocols of their work center on the publication of patient data.

Right to privacy and informed consent

The authors declare that no patient data appear in this article.

Conflicts of Interest

The authors declare they have no conflicts of interest.

A. Rattanasirivilai, A. Kurban, Y.M. Lenzy, R. Yaar.
Cutaneous metastasis of prostatic adenocarcinoma: a cautionary tale.
J Cutan Pathol, 38 (2011), pp. 521-524
S. Riley, T. Wah.
Cutaneous metastasis of esophageal adenocarcinoma with an unusual presentation.
J Clin Ultrasound, 35 (2007), pp. 289-292
D. He, J. Zeng, X. Li, K. Wu, D. Wu, H. He, et al.
Priapism as the initial manifestation of a penile and lower limb cutaneous metastasis of prostate adenocarcinoma with low serum PSA level.
J Androl, 33 (2012), pp. 1160-1164
S. Nalbant, H. Corominas, B. Hsu, L.X. Chen, H.R. Schumacher, T. Kitumnuaypong.
Ultrasonography for assessment of subcutaneous nodules.
J Rheumatol, 30 (2003), pp. 1191-1195

Please cite this article as: Corominas H, Estrada P, Reina D, Cerdà-Gabaroi D. Ecografía en el diagnóstico de metástasis cutánea de adenocarcinoma de próstata. Reumatol Clin. 2016;12:54–56.

Copyright © 2015. Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología
Reumatología Clínica (English Edition)

Subscribe to our newsletter

Article options
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.